AAAAAA

   
Results: 1-8 |
Results: 8
THE INFLUENCE OF UPPER ABDOMINAL-SURGERY ON PERIOPERATIVE MORBIDITY AND MORTALITY IN PATIENTS WITH ADVANCED OVARIAN-CANCER FIGO-III AND FIGO-IV
Authors: KUHN W FLORACK G RODER J SCHMALFELDT B PACHE L RUST M ULM K SPATHE K JANICKE F SIEWERT JR GRAEFF H
Citation: W. Kuhn et al., THE INFLUENCE OF UPPER ABDOMINAL-SURGERY ON PERIOPERATIVE MORBIDITY AND MORTALITY IN PATIENTS WITH ADVANCED OVARIAN-CANCER FIGO-III AND FIGO-IV, International journal of gynecological cancer, 8(1), 1998, pp. 56-63
DISEASE-ADAPTED RELAPSE THERAPY FOR OVARIAN-CANCER - RESULTS OF A PROSPECTIVE-STUDY
Authors: KUHN W SCHMALFELDT B PACHE L SPATHE K ULM K RENZIEHAUSEN K NOSCHEL H CANZLER E RICHTER B KRONER M TILCH G JANICKE F GRAEFF H
Citation: W. Kuhn et al., DISEASE-ADAPTED RELAPSE THERAPY FOR OVARIAN-CANCER - RESULTS OF A PROSPECTIVE-STUDY, International journal of oncology, 13(1), 1998, pp. 57-63
MUTATIONAL ANALYSIS OF THE GENES ENCODING UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND ITS INHIBITOR PAI-1 IN ADVANCED OVARIAN-CANCER
Authors: TURKMEN B SCHMITT M SCHMALFELDT B TROMMLER P HELL W CREUTZBURG S GRAEFF H MAGDOLEN V
Citation: B. Turkmen et al., MUTATIONAL ANALYSIS OF THE GENES ENCODING UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND ITS INHIBITOR PAI-1 IN ADVANCED OVARIAN-CANCER, Electrophoresis, 18(5), 1997, pp. 686-689
ORAL AND PARENTERAL ETOPOSIDE IN PLATINUM REFRACTORY OVARIAN-CANCER PATIENTS - RESULTS OF A PROSPECTIVE RANDOMIZED STUDY
Authors: KUHN W SCHMALFELDT B DOSE J PACHE L ULM K FREITAG K JANICKE F GRAEFF H
Citation: W. Kuhn et al., ORAL AND PARENTERAL ETOPOSIDE IN PLATINUM REFRACTORY OVARIAN-CANCER PATIENTS - RESULTS OF A PROSPECTIVE RANDOMIZED STUDY, Geburtshilfe und Frauenheilkunde, 56(2), 1996, pp. 105-110
PUERPERAL OVARIAN VEIN-THROMBOSIS (POVT) CONSERVATIVE MANAGEMENT WITHCT-GUIDED FOLLOW-UP MONITORING
Authors: KUHN W SCHMALFELDT B LENZ M LOOS W
Citation: W. Kuhn et al., PUERPERAL OVARIAN VEIN-THROMBOSIS (POVT) CONSERVATIVE MANAGEMENT WITHCT-GUIDED FOLLOW-UP MONITORING, Geburtshilfe und Frauenheilkunde, 55(5), 1995, pp. 287-289
PRIMARY TUMOR AND METASTASIS IN OVARIAN-CANCER DIFFER IN THEIR CONTENT OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, ITS RECEPTOR, AND INHIBITORS TYPE-1 AND TYPE-2
Authors: SCHMALFELDT B KUHN W REUNING U PACHE L DETTMAR P SCHMITT M JANICKE F HOFLER H GRAEFF H
Citation: B. Schmalfeldt et al., PRIMARY TUMOR AND METASTASIS IN OVARIAN-CANCER DIFFER IN THEIR CONTENT OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, ITS RECEPTOR, AND INHIBITORS TYPE-1 AND TYPE-2, Cancer research, 55(18), 1995, pp. 3958-3963
UROKINASE (UPA) AND PAI-1 PREDICT SURVIVAL IN ADVANCED OVARIAN-CANCERPATIENTS (FIGO-III) AFTER RADICAL SURGERY AND PLATINUM-BASED CHEMOTHERAPY
Authors: KUHN W PACHE L SCHMALFELDT B DETTMAR P SCHMITT M JANICKE F GRAEFF H
Citation: W. Kuhn et al., UROKINASE (UPA) AND PAI-1 PREDICT SURVIVAL IN ADVANCED OVARIAN-CANCERPATIENTS (FIGO-III) AFTER RADICAL SURGERY AND PLATINUM-BASED CHEMOTHERAPY, Gynecologic oncology, 55(3), 1994, pp. 401-409
DEVELOPMENT IN THE THERAPY OF THE ADVANCED OVARIAN-CANCER FIGO-III
Authors: KUHN W JANICKE F PACHE L HOLSCHER M SCHATTENMANN G SCHMALFELDT B ANDERL H SCHULE G DETTMAR P SIEWERT JR GRAEFF H
Citation: W. Kuhn et al., DEVELOPMENT IN THE THERAPY OF THE ADVANCED OVARIAN-CANCER FIGO-III, Geburtshilfe und Frauenheilkunde, 53(5), 1993, pp. 293-302
Risultati: 1-8 |